![Matthew Brennan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Brennan
Direktor/Vorstandsmitglied bei Scinapsis Analytics, Inc.
Aktive Positionen von Matthew Brennan
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Scinapsis Analytics, Inc.
![]() Scinapsis Analytics, Inc. Miscellaneous Commercial ServicesCommercial Services Scinapsis Analytics, Inc., also known as BenchSci, is a company based in Toronto, Canada. BenchSci is a world leader in AI solutions for preclinical R&D. The Canadian company provides resources to help organizations make the most of their platform, which leads to quantifiable productivity gains, recouped research capacity, and a reduction in spend. The company's proprietary technology helps decode the complexity of biomedical research. Scinapsis Analytics, Inc. also offers ASCEND, an innovative platform that empowers scientists to optimize their experimental approach at every stage of drug discovery. The company was founded by Pushparaj Abhi. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Matthew Brennan
Statistik
International
Kanada | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Scinapsis Analytics, Inc.
![]() Scinapsis Analytics, Inc. Miscellaneous Commercial ServicesCommercial Services Scinapsis Analytics, Inc., also known as BenchSci, is a company based in Toronto, Canada. BenchSci is a world leader in AI solutions for preclinical R&D. The Canadian company provides resources to help organizations make the most of their platform, which leads to quantifiable productivity gains, recouped research capacity, and a reduction in spend. The company's proprietary technology helps decode the complexity of biomedical research. Scinapsis Analytics, Inc. also offers ASCEND, an innovative platform that empowers scientists to optimize their experimental approach at every stage of drug discovery. The company was founded by Pushparaj Abhi. | Commercial Services |
- Börse
- Insiders
- Matthew Brennan
- Erfahrung